BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/14/2021 11:08:13 AM | Browse: 374 | Download: 642
 |
Received |
|
2021-02-20 19:47 |
|
Peer-Review Started |
|
2021-02-20 19:56 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-04-06 05:31 |
|
Revised |
|
2021-04-19 19:05 |
|
Second Decision |
|
2021-07-07 12:55 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-07-07 14:00 |
|
Articles in Press |
|
2021-07-07 14:00 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-08-02 00:28 |
|
Publish the Manuscript Online |
|
2021-08-14 11:08 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
B7 homologue 3 as a prognostic biomarker and potential therapeutic target in gastrointestinal tumors
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Petar Rasic, Maja Jovanovic-Tucovic, Marija Jeremic, Slavisa M Djuricic, Zorica V Vasiljevic, Maja Milickovic and Djordje Savic |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Ministry of Education, Science and Technological Development of the Republic of Serbia |
41025 |
|
| Corresponding Author |
Petar Rasic, MD, Doctor, Department of Abdominal Surgery, Mother and Child Health Care Institute of Serbia “Dr. Vukan Cupic“, Radoja Dakica 6-8, Belgrade 11 000, Serbia. petar.rasic@imd.org.rs |
| Key Words |
B7 homologue 3; Gastrointestinal tumors; Colorectal cancer; Gastric cancer; Esophageal cancer; Targeted therapy |
| Core Tip |
Limitations related to oncotherapy and poor survival of patients with advanced forms of the most common malignant tumors of the gastrointestinal tract, including colorectal, gastric, and esophageal cancers (ECs), have led researchers to investigate new molecular target-driven therapeutic approaches. B7 homologue 3 (B7-H3) was shown to be significantly overexpressed among various malignancies and associated with their progression, metastasis and resistance to anticancer therapy. In this review, we analyze the results of different studies related to B7-H3 in colorectal, gastric, and ECs and suggest that this molecule could be a promising prognostic biomarker and therapeutic target in these tumors. |
| Publish Date |
2021-08-14 11:08 |
| Citation |
Rasic P, Jovanovic-Tucovic M, Jeremic M, Djuricic SM, Vasiljevic ZV, Milickovic M, Savic D. B7 homologue 3 as a prognostic biomarker and potential therapeutic target in gastrointestinal tumors. World J Gastrointest Oncol 2021; 13(8): 799-821 |
| URL |
https://www.wjgnet.com/1948-5204/full/v13/i8/799.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v13.i8.799 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
